check_circleStudy Completed

Contraception

Comparison to investigate the influence of Yasmin® vs Microgynon 30® on various parameters associated with well-being in healthy female subjects

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

16 - 40 Years
  • -

  • -

Trial summary

Enrollment Goal
424
Trial Dates
May 2001 - June 2002
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteer
N/A

Trial design

Multicenter, single-blind, randomized, parallel-group comparison to investigate the influence of Yasmin® (SH T 470 FA: 30μg ethinylestradiol, 3mg drospirenone) vs Microgynon 30® (SH 7.1155 A: 30μg ethinylestradiol, 150μg levonorgestrel) on various parameters associated with well-being for 7 cycles in healthy female subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A